Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo
- PMID: 20657761
- PMCID: PMC2908089
- DOI: 10.1109/JSTQE.2009.2033609
Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo
Abstract
Optical microangiography (OMAG) is a recently developed volumetric imaging technique that is capable of producing 3D images of dynamic blood perfusion within microcirculatory tissue beds in vivo. The imaging contrast of OMAG image is based on the intrinsic optical scattering signals backscattered by the moving blood cells in patent blood vessels, thus it is a label free imaging technique. In this paper, I will first discuss its recent developments that use a constant modulation frequency introduced in the spectral interferograms to achieve the blood perfusion imaging. I will then introduce its latest development that utilizes the inherent blood flow to modulate the spectral interferograms to realize the blood perfusion imaging. Finally, examples of using OMAG to delineate the dynamic blood perfusion, down to capillary level resolution, within living tissues are given, including cortical blood perfusion in the brain of small animals and blood flow within human retina and choroids.
Figures









References
-
- Yamada E, Matsumura M, Kyo S, Omoto R. Usefulness of a prototype intravascular ultrasound imaging in evaluation of aortic dissection and comparison with angiographic study, transesophageal echocardiography, computed tomography and magnetic resonance imaging. Am J. Cardiol. 1995;75:161–171. - PubMed
-
- Misgeld T, Kerschensteiner M. In vivo imaging of the diseased nervous system. Nature Rev. Neurosci. 2006;7:449–463. - PubMed
-
- Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke. 2005;36:2311–20. - PubMed
-
- Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2004;126S:483–512. the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. - PubMed
-
- Fisher M, Fernandez JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin JH. Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation. Stroke. 1996;27:1163–6. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources